NO995300D0 - Anvendelse av 1-ar(alk)yl-imidazolin-2-on for behandling av angst- og spenningstilstander - Google Patents

Anvendelse av 1-ar(alk)yl-imidazolin-2-on for behandling av angst- og spenningstilstander

Info

Publication number
NO995300D0
NO995300D0 NO995300A NO995300A NO995300D0 NO 995300 D0 NO995300 D0 NO 995300D0 NO 995300 A NO995300 A NO 995300A NO 995300 A NO995300 A NO 995300A NO 995300 D0 NO995300 D0 NO 995300D0
Authority
NO
Norway
Prior art keywords
imidazolin
alk
anxiety
treatment
stress conditions
Prior art date
Application number
NO995300A
Other languages
English (en)
Other versions
NO325346B1 (no
NO995300L (no
Inventor
Angelika Rostock
Rita Dost
Christine Tober
Reni Bartsch
Klaus Unverferth
Chris Rundfeldt
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of NO995300L publication Critical patent/NO995300L/no
Publication of NO995300D0 publication Critical patent/NO995300D0/no
Publication of NO325346B1 publication Critical patent/NO325346B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19995300A 1997-05-23 1999-10-29 Anvendelse av 1-ar(alk)yl-imidazolin-2-on for behandling av angst- og spenningstilstander NO325346B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19721580A DE19721580A1 (de) 1997-05-23 1997-05-23 Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
PCT/DE1998/001343 WO1998052548A2 (de) 1997-05-23 1998-05-14 Verwendung von 1-ar(alk)yl-imidazolin-2-one zur behandlung von angst- und spannungszuständen
US09/079,802 US5994347A (en) 1997-05-23 1998-05-15 For a process for treatment of anxiety and tension

Publications (3)

Publication Number Publication Date
NO995300L NO995300L (no) 1999-10-29
NO995300D0 true NO995300D0 (no) 1999-10-29
NO325346B1 NO325346B1 (no) 2008-04-07

Family

ID=26036759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995300A NO325346B1 (no) 1997-05-23 1999-10-29 Anvendelse av 1-ar(alk)yl-imidazolin-2-on for behandling av angst- og spenningstilstander

Country Status (25)

Country Link
US (1) US5994347A (no)
EP (1) EP0979083B1 (no)
JP (1) JP4838403B2 (no)
CN (1) CN1150901C (no)
AR (1) AR012746A1 (no)
AT (1) ATE246926T1 (no)
AU (1) AU745536B2 (no)
BG (1) BG63378B1 (no)
BR (1) BR9809666A (no)
CA (1) CA2291075C (no)
DE (2) DE19721580A1 (no)
DK (1) DK0979083T3 (no)
ES (1) ES2205516T3 (no)
HU (1) HUP0003108A3 (no)
IL (1) IL132652A0 (no)
NO (1) NO325346B1 (no)
NZ (1) NZ500849A (no)
PL (1) PL193589B1 (no)
PT (1) PT979083E (no)
RU (1) RU2203055C2 (no)
SK (1) SK284258B6 (no)
TR (1) TR199902815T2 (no)
TW (1) TW579294B (no)
WO (1) WO1998052548A2 (no)
ZA (1) ZA984197B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
CA2531861A1 (en) * 2003-07-11 2005-01-20 Elbion Ag Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
CA2576344C (en) 2004-08-11 2010-10-05 Cadbury Adams Usa Llc Warming compositions and delivery systems therefor
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
DE19532668A1 (de) * 1995-09-05 1997-03-06 Dresden Arzneimittel Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
US5869481A (en) * 1995-09-05 1999-02-09 Arzneitmittelwerk Dresden G.M.B.H. Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making

Also Published As

Publication number Publication date
ES2205516T3 (es) 2004-05-01
TR199902815T2 (xx) 2000-08-21
HUP0003108A2 (hu) 2001-05-28
PT979083E (pt) 2003-12-31
DK0979083T3 (da) 2003-12-01
WO1998052548A2 (de) 1998-11-26
BG63378B1 (bg) 2001-12-29
SK284258B6 (sk) 2004-12-01
NO325346B1 (no) 2008-04-07
DE59809285D1 (de) 2003-09-18
CA2291075A1 (en) 1998-11-26
AU745536B2 (en) 2002-03-21
AR012746A1 (es) 2000-11-08
NO995300L (no) 1999-10-29
CA2291075C (en) 2006-04-04
JP2001525829A (ja) 2001-12-11
ZA984197B (en) 1998-06-24
PL193589B1 (pl) 2007-02-28
IL132652A0 (en) 2001-03-19
PL337090A1 (en) 2000-07-31
WO1998052548A3 (de) 1999-04-22
CN1260717A (zh) 2000-07-19
HUP0003108A3 (en) 2001-07-30
AU8332698A (en) 1998-12-11
SK158499A3 (en) 2001-03-12
NZ500849A (en) 2001-09-28
DE19721580A1 (de) 1998-11-26
ATE246926T1 (de) 2003-08-15
BR9809666A (pt) 2000-07-11
US5994347A (en) 1999-11-30
EP0979083B1 (de) 2003-08-13
EP0979083A2 (de) 2000-02-16
TW579294B (en) 2004-03-11
JP4838403B2 (ja) 2011-12-14
RU2203055C2 (ru) 2003-04-27
BG103859A (en) 2000-07-31
CN1150901C (zh) 2004-05-26

Similar Documents

Publication Publication Date Title
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
DE69817015D1 (de) Gerät und methode zur wirkungsbegrenzung von detonationen
DE69810696T2 (de) Prüfanordnung und Prüfverfahren
EE03928B1 (et) Meetod N-alküülitud aspartaamiderivaadi valmistamiseks ja puhastamiseks
DE59609764D1 (de) Endosphinkter und set zum freigebbaren verschliessen der urethra
DE69739494D1 (de) Gerät zur Fixation der Wirbelsäule
NO984094L (no) Utladningsreaktor og anvendelse av samme
DE69840108D1 (de) Versuchsverfahren und vorrichtung
DE59710130D1 (de) Verwendung verbindungsverfahrens und verbindungsverfahren
NO983632L (no) Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid
DK0961609T3 (da) Fremgangsmåde til forbedring af sundhedstilstanden af hår og hovedbund
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
DE60014621D1 (de) Zentrifugationsvorrichtung und verwendung dieser vorrichtung
ID22220A (id) Elemen pelekat dengan kulit pengisap
ITTO950529A0 (it) Dispositivo e procedimento per la realizzazione di catene di ortidoti lunghezza ridotta
DE1017910T1 (de) Element und system für dachverkleidungen und anwendung dieser elemente
DE29718503U1 (de) Gerät zur Behandlung von Tinitus und Hyperakusis
NO995300L (no) Anvendelse av 1-ar(alk)yl-imidazolin-2-on for behandling av angst- og spenningstilstander
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
ID21289A (id) Metode perekatan dan peralatan daripadanya
DE69813119D1 (de) Optisches Beobachtungssystem und optisches Gerät unter Verwendung desselben
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
DE29511204U1 (de) Zentrier- und Befestigungsvorrichtung sowie mechanisches Verbindungselement zur Verwendung darin
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees